Eco-friendly nanoparticles improve cidofovir’s anticancer and antiviral effects
“This environmentally friendly technique represents a novel approach to nanoparticle fabrication, emphasizing sustainability in nanotechnology”
2025-11-10
(Press-News.org)
“This environmentally friendly technique represents a novel approach to nanoparticle fabrication, emphasizing sustainability in nanotechnology.”
BUFFALO, NY – November 10, 2025 – A new research paper was published in Oncotarget (Volume 16) on November 6, 2025, titled “Anti-DNA virus agent cidofovir – loaded green synthesized cerium oxide nanoparticles (Nanoceria): Nucleic acids (DNA and RNA) binding affinity and cytotoxicity effects.”
In this study, led by Nahid Shahabadi from Razi University in Kermanshah, researchers developed an environmentally friendly approach to enhance the performance of cidofovir, a drug used to treat infections caused by DNA viruses. The work responds to the growing need for therapies that are safer, more effective, and better targeted.
The research team developed a new compound by loading cidofovir onto green-synthesized cerium oxide nanoparticles (nanoceria), known as CDV-CeO2 NPs. This method combines the drug’s antiviral and anticancer properties with the biological activity of nanoceria, which is known for its antioxidant, anti-inflammatory, and tumor-targeting effects. To avoid toxic chemicals, the nanoparticles were synthesized using quince fruit peel extract, making the process more sustainable and suitable for medical applications.
Laboratory experiments showed that the CDV-CeO2 nanoparticles were significantly more effective at killing breast cancer cells than either cidofovir or cerium oxide nanoparticles alone. At the highest tested concentration, the new compound destroyed more than 97% of cancer cells, compared to 72% with cidofovir alone and 50% with nanoparticles alone. These findings suggest that the combined formulation enhances anticancer activity and may allow for lower drug doses with fewer side effects.
To understand how these nanoparticles interact with genetic material, the team studied their binding to DNA and RNA, two key molecules involved in cancer development and viral replication. CDV-CeO2 nanoparticles showed strong binding affinity through two mechanisms: groove binding, which fits into natural curves of the genetic molecule strands, and intercalation, which inserts between base pairs. The nanoparticles formed stable complexes that responded to temperature, indicating reliable interactions in biological systems.
“The novelty of this work lies in the innovative green synthesis method, the dual-functional therapeutic application, and the enhanced biological activity of the CDV-CeO2 NPs, which collectively position these nanoparticles as promising candidates for future cancer and antiviral therapies.”
This research presents a potential new strategy for improving drug targeting and delivery using green nanotechnology. The approach could lead to more effective treatments for diseases such as breast cancer and infections caused by human papillomavirus (HPV) and other DNA viruses. However, further research, including animal and clinical studies, is needed to confirm the safety and long-term effectiveness of this treatment.
Overall, this study represents a significant step toward combining natural materials with nanomedicine to create more efficient therapies. If supported by future research, CDV-CeO2 nanoparticles could offer a new generation of dual-action treatments.
DOI: https://doi.org/10.18632/oncotarget.28774
Correspondence to: Nahid Shahabadi- nahidshahabadi@yahoo.com
Abstract video: https://www.youtube.com/watch?v=Il9CsfgO2mU
Keywords: cancer, CeO2 NPs, green synthesis, DNA interaction, RNA interaction, cytotoxicity
Click here to sign up for free Altmetric alerts about this article.
________
About Oncotarget:
Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
X
Facebook
YouTube
Instagram
LinkedIn
Pinterest
Spotify, and available wherever you listen to podcasts
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact media@impactjournals.com
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-11-10
What factors help English learners (ELs) succeed in schools? In a study of top performing New York City high schools serving immigrant ELs, researchers linked three conditions—teacher autonomy, collaboration, and collective responsibility—to higher credit attainment.
“Most research on ELs focuses on classroom instruction or broader language policies, but our study describes the professional conditions that positively impact outcomes for immigrant ELs,” says Adriana Villavicencio, lead author and assistant professor of educational leadership and policy studies at NYU Steinhardt. “We took this approach to address a dearth ...
2025-11-10
In 2023, astronomers detected a huge collision. Two unprecedentedly massive black holes had crashed an estimated 7 billion light-years away. The enormous masses and extreme spins of the black holes puzzled astronomers. Black holes like these were not supposed to exist.
Now, astronomers with the Flatiron Institute’s Center for Computational Astrophysics (CCA) and their colleagues have figured out just how these black holes may have formed and collided. The astronomers’ comprehensive simulations — which follow the system from the lives of the parent stars through to their ultimate death — uncovered ...
2025-11-10
Blue Zones and the American College of Lifestyle Medicine (ACLM) today launched the “Blue Zones Certification Course for Physicians and Health Professionals.” The new certification recognizes clinicians with the knowledge and tools to promote longevity, well-being, and health equity—both in the exam room and in their communities.
The certification integrates Blue Zones' evidence-based roadmap to living better and longer, rooted in their identification of and research from the world's longest-lived and happiest cultures—the blue zones regions—with ACLM's ...
2025-11-10
SAN ANTONIO — November 10, 2025 — Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.
SwRI scientists used the bioreactor to replicate induced Pluripotent Stem Cells (iPSCs) derived from adult skin, blood, and other somatic cells. Their pluripotent state allows iPSCs to differentiate into any other cell type in the body, much like embryonic stem cells but without the same ethical ambiguity. Large quantities ...
2025-11-10
Trial Showing Ivermectin Safety in Small Children Could Spur Progress Against Several Neglected Tropical Diseases
TORONTO (November 10, 2025)—Millions of very young children currently excluded from treatment with the drug ivermectin could be safely included in ongoing campaigns against challenging and often neglected tropical diseases such as intestinal worms, scabies and river blindness, according to results from a clinical trial presented today at the Annual Meeting of the American Society ...
2025-11-10
PLYMOUTH MEETING, PA [November 10, 2025] — New research in the November 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network explores the perceptions regarding the effectiveness of team-based and technology-based approaches for supportive care for people with cancer. The ongoing supportive care study includes discussions on patient goals, values, and preferences, in addition to symptom management. According to the results from this mixed-methods study, 87.5% of team-based clinic participants perceived that method is more ...
2025-11-10
New York, NY (November 10 2025) — In a high honor, Jean-Frédéric Colombel, MD, a leading inflammatory bowel disease (IBD) expert at the Icahn School of Medicine at Mount Sinai, will deliver the 31st Anatomy Lesson on Thursday, November 20, at the Concertgebouw in Amsterdam. His lecture, “Tackling the Growing Problem of Immune Diseases—Crohn’s Disease as an Example,” will explore Mount Sinai’s pioneering work in the early detection, prevention, and treatment of IBD.
The Anatomy Lesson, an annual public lecture organized by Amsterdam UMC, invites leading international physicians and researchers to reflect on medicine’s ...
2025-11-10
When researchers look for potential cancer therapy targets, they typically go after protein-coding genes that participate in disease progression. Disrupt them and negate whatever role they play in cancer’s development or spread. Researchers at Cold Spring Harbor Laboratory (CSHL) have also been working on another kind of target. They’re studying a long non-coding RNA called MALAT1. So far, it’s been linked to more than 20 different types of tumors.
In a new and unique study published in Molecular Therapy: Oncology, CSHL researchers track MALAT1 levels ...
2025-11-10
ORLANDO (NOV. 9, 2025) – Allergist Cherie Zachary, MD, of Bloomington, MN was installed as president of the American College of Allergy, Asthma and Immunology (ACAAI) at the ACAAI Annual Scientific Meeting on November 10 in Orlando. Allergist David Stukus, MD, of Columbus, OH, was elected ACAAI president-elect.
Other newly-elected ACAAI officers are Maureen Petersen, MD, of Clayton, NC, as vice president and Melinda Rathkopf, MD, MBA, of Atlanta, GA, as treasurer. Regents elected for three-year terms include Christopher C. Chang, MD, PhD, MBA, Hollywood, Florida, Mitchell H. Grayson, MD, Columbus, OH, and Jay A. Lieberman, ...
2025-11-10
More than 99% of the world’s 7.7 billion people have one or more of their environmental rights threatened, according to new research.
In the most comprehensive analysis of inequality in environmental conditions to date, CU Boulder researchers revealed that nearly half of the global population lives in regions facing three or more environmental problems. Those include polluted air, unsafe water, extreme heat, food insecurity and biodiversity loss.
The analysis was published September 25 in Environmental Research Communications.
It provides strong ...
LAST 30 PRESS RELEASES:
[Press-News.org] Eco-friendly nanoparticles improve cidofovir’s anticancer and antiviral effects
“This environmentally friendly technique represents a novel approach to nanoparticle fabrication, emphasizing sustainability in nanotechnology”
